Intravenous intralipid therapy in recurrent implantation failure: Biological rationale, clinical evidence, and ongoing controversies

Philippe Attieh, Sarah Chendab, Joya Ghaleb, Nadia Katrib, Hilda E. Ghadieh, Emile Dabaj

Open source

DOI
10.1016/j.jogoh.2026.103251
Published
2026-11
Container
Journal of Gynecology Obstetrics and Human Reproduction
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jogoh.2026.103251,
  title = {Intravenous intralipid therapy in recurrent implantation failure: Biological rationale, clinical evidence, and ongoing controversies},
  author = {Philippe Attieh and Sarah Chendab and Joya Ghaleb and Nadia Katrib and Hilda E. Ghadieh and Emile Dabaj},
  year = {2026},
  journal = {Journal of Gynecology Obstetrics and Human Reproduction},
  doi = {10.1016/j.jogoh.2026.103251},
  url = {https://doi.org/10.1016/j.jogoh.2026.103251}
}

RIS

TY  - JOUR
TI  - Intravenous intralipid therapy in recurrent implantation failure: Biological rationale, clinical evidence, and ongoing controversies
AU  - Philippe Attieh
AU  - Sarah Chendab
AU  - Joya Ghaleb
AU  - Nadia Katrib
AU  - Hilda E. Ghadieh
AU  - Emile Dabaj
PY  - 2026
JO  - Journal of Gynecology Obstetrics and Human Reproduction
DO  - 10.1016/j.jogoh.2026.103251
UR  - https://doi.org/10.1016/j.jogoh.2026.103251
ER  - 

APA

Attieh, P., Chendab, S., Ghaleb, J., Katrib, N., Ghadieh, H. E., & Dabaj, E. (2026). Intravenous intralipid therapy in recurrent implantation failure: Biological rationale, clinical evidence, and ongoing controversies. Journal of Gynecology Obstetrics and Human Reproduction. https://doi.org/10.1016/j.jogoh.2026.103251

Source records